Terms: = Prostate cancer AND MUC16, CA125, CA-125
169 results:
1. Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.
Wan L; Fan Y; Wu T; Liu Y; Zhang R; Chen S; Zhao C; Xue Y
Eur J Med Res; 2024 Apr; 29(1):242. PubMed ID: 38643190
[TBL] [Abstract] [Full Text] [Related]
2. Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers.
Gronnier M; Hedhli K; Sauzay C; Salle V; Duhaut P; Schmidt J; Dernoncourt A
BMC Cancer; 2024 Apr; 24(1):468. PubMed ID: 38622530
[TBL] [Abstract] [Full Text] [Related]
3. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
4. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.
van Rossum HH; Holdenrieder S; Ballieux BEPB; Badrick TC; Yun YM; Zhang C; Patel D; Thelen M; Song J; Wojtalewicz N; Unsworth N; Vesper HW; Cui W; Ramanathan LV; Sturgeon C; Meng QH
Clin Chem; 2024 Apr; 70(4):669-679. PubMed ID: 38385453
[TBL] [Abstract] [Full Text] [Related]
5. Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays.
Galior KD; Ladwig PM; Snyder MR; Algeciras-Schimnich A; Bornhorst JA; Block DR; Baumann NA; Willrich MAV
Clin Biochem; 2023 Nov; 121-122():110685. PubMed ID: 37972806
[TBL] [Abstract] [Full Text] [Related]
6. Tumour Marker Requisition Pattern in a Tertiary Care Centre of Eastern Nepal.
Niraula A; Gelal B; Chaudhari RK; Das BK; Lamsal M
Kathmandu Univ Med J (KUMJ); 2022; 20(80):422-426. PubMed ID: 37795716
[TBL] [Abstract] [Full Text] [Related]
7. Electrochemical aptasensor based on the engineered core-shell MOF nanostructures for the detection of tumor antigens.
Khan S; Cho WC; Sepahvand A; Haji Hosseinali S; Hussain A; Nejadi Babadaei MM; Sharifi M; Falahati M; Jaragh-Alhadad LA; Ten Hagen TLM; Li X
J Nanobiotechnology; 2023 Apr; 21(1):136. PubMed ID: 37101280
[TBL] [Abstract] [Full Text] [Related]
8. Quantification of overdiagnosis in randomised trials of cancer screening: an overview and re-analysis of systematic reviews.
Voss T; Krag M; Martiny F; Heleno B; Jørgensen KJ; Brandt Brodersen J
Cancer Epidemiol; 2023 Jun; 84():102352. PubMed ID: 36963292
[TBL] [Abstract] [Full Text] [Related]
9. Molecularly Imprinted Polymers for the Determination of cancer Biomarkers.
Pilvenyte G; Ratautaite V; Boguzaite R; Ramanavicius A; Viter R; Ramanavicius S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835517
[TBL] [Abstract] [Full Text] [Related]
10. 68 Ga-prostate-Specific Membrane Antigen PET/CT in Ovarian Tumors : Potential to Differentiate Benign and Malignant Tumors Before Surgery: A Preliminary Report.
Kunikowska J; Bizoń M; Pełka K; Derlatka P; Olszewski M; Królicki L
Clin Nucl Med; 2023 Feb; 48(2):e60-e66. PubMed ID: 36512649
[TBL] [Abstract] [Full Text] [Related]
11. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
[TBL] [Abstract] [Full Text] [Related]
12. FLG Gene Mutation Up-regulates the Abnormal Tumor Immune Response and Promotes the Progression of prostate cancer.
Zhang P; An Z; Sun C; Xu Y; Zhang Z
Curr Pharm Biotechnol; 2022; 23(14):1658-1670. PubMed ID: 35422210
[TBL] [Abstract] [Full Text] [Related]
13. Genome-wide association study of serum tumor markers in Southern Chinese Han population.
Li X; Bai F; Wei X; Jin T; Li C; Zhang Y; Lin M; Zhou X; Xie Y; He C; Lin Q; He P; Chu S; Ding Y
BMC Cancer; 2022 Feb; 22(1):160. PubMed ID: 35144566
[TBL] [Abstract] [Full Text] [Related]
14. RBAC and Its Role with the Immune System.
Pescatore F; Prestano C; Kichikova M
Altern Ther Health Med; 2022 Jan; 28(1):8-10. PubMed ID: 35120333
[TBL] [Abstract] [Full Text] [Related]
15. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
Zhang L; Chen H; Ding B; Jiang W
J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
[TBL] [Abstract] [Full Text] [Related]
16. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract] [Full Text] [Related]
17. Flexible diagnostic measures and new cut-point selection methods under multiple ordered classes.
Feng Y; Tian L
Pharm Stat; 2022 Jan; 21(1):220-240. PubMed ID: 34449107
[TBL] [Abstract] [Full Text] [Related]
18. The Combination of ca125 and NSE Is Useful for Predicting Liver Metastasis of Lung cancer.
Wang CF; Peng SJ; Liu RQ; Yu YJ; Ge QM; Liang RB; Li QY; Li B; Shao Y
Dis Markers; 2020; 2020():8850873. PubMed ID: 33376560
[TBL] [Abstract] [Full Text] [Related]
19. Nanotechnology in ovarian cancer: Diagnosis and treatment.
Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
[TBL] [Abstract] [Full Text] [Related]
20. Inappropriate practice in tumor marker requests at a university hospital in Western Saudi Arabia: A 3-year retrospective study.
Al-Mughales JA; Alahwal MS
Int J Biol Markers; 2020 Dec; 35(4):35-43. PubMed ID: 33158390
[TBL] [Abstract] [Full Text] [Related]
[Next]